Cargando…

The severe COVID-19: A sepsis induced by viral infection? And its immunomodulatory therapy

COVID-19 is known for its magical infectivity, fast transmission and high death toll based on the large number of infected people. From the perspective of the clinical manifestation, autopsy examination and pathophysiology, the essence of COVID-19 should be viewed as a sepsis induced by viral infect...

Descripción completa

Detalles Bibliográficos
Autor principal: Lin, Hong-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7451584/
https://www.ncbi.nlm.nih.gov/pubmed/32690231
http://dx.doi.org/10.1016/j.cjtee.2020.06.002
_version_ 1783575008581255168
author Lin, Hong-Yuan
author_facet Lin, Hong-Yuan
author_sort Lin, Hong-Yuan
collection PubMed
description COVID-19 is known for its magical infectivity, fast transmission and high death toll based on the large number of infected people. From the perspective of the clinical manifestation, autopsy examination and pathophysiology, the essence of COVID-19 should be viewed as a sepsis induced by viral infection, and has the essential characteristics as sepsis induced by other pathogens. Therefore, in addition to etiological and supportive treatment, immunomodulatory therapy is also appropriate to severe COVID-19. Although there is still a lack of consensus on immunotherapy for sepsis so far, relatively rich experiences have been accumulated in the past decades, which will help us in the treatment of severe COVID-19. This article will elaborate immunotherapy of sepsis, though it may not be consistent.
format Online
Article
Text
id pubmed-7451584
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-74515842020-08-31 The severe COVID-19: A sepsis induced by viral infection? And its immunomodulatory therapy Lin, Hong-Yuan Chin J Traumatol Special Topic on Critical Care in COVID-19 COVID-19 is known for its magical infectivity, fast transmission and high death toll based on the large number of infected people. From the perspective of the clinical manifestation, autopsy examination and pathophysiology, the essence of COVID-19 should be viewed as a sepsis induced by viral infection, and has the essential characteristics as sepsis induced by other pathogens. Therefore, in addition to etiological and supportive treatment, immunomodulatory therapy is also appropriate to severe COVID-19. Although there is still a lack of consensus on immunotherapy for sepsis so far, relatively rich experiences have been accumulated in the past decades, which will help us in the treatment of severe COVID-19. This article will elaborate immunotherapy of sepsis, though it may not be consistent. Elsevier 2020-08 2020-06-15 /pmc/articles/PMC7451584/ /pubmed/32690231 http://dx.doi.org/10.1016/j.cjtee.2020.06.002 Text en © 2020 Production and hosting by Elsevier B.V. on behalf of Chinese Medical Association. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Special Topic on Critical Care in COVID-19
Lin, Hong-Yuan
The severe COVID-19: A sepsis induced by viral infection? And its immunomodulatory therapy
title The severe COVID-19: A sepsis induced by viral infection? And its immunomodulatory therapy
title_full The severe COVID-19: A sepsis induced by viral infection? And its immunomodulatory therapy
title_fullStr The severe COVID-19: A sepsis induced by viral infection? And its immunomodulatory therapy
title_full_unstemmed The severe COVID-19: A sepsis induced by viral infection? And its immunomodulatory therapy
title_short The severe COVID-19: A sepsis induced by viral infection? And its immunomodulatory therapy
title_sort severe covid-19: a sepsis induced by viral infection? and its immunomodulatory therapy
topic Special Topic on Critical Care in COVID-19
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7451584/
https://www.ncbi.nlm.nih.gov/pubmed/32690231
http://dx.doi.org/10.1016/j.cjtee.2020.06.002
work_keys_str_mv AT linhongyuan theseverecovid19asepsisinducedbyviralinfectionanditsimmunomodulatorytherapy
AT linhongyuan severecovid19asepsisinducedbyviralinfectionanditsimmunomodulatorytherapy